Secret Dry Spray Antiperspirant Recalled for Potential Benzene Contamination
The FDA has recalled Secret Dry Spray Antiperspirant in Waterlily scent due to potential benzene contamination at the manufacturing facility. All lots with expiration dates through September 2023 are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall is rated High because benzene contamination represents a risk-of-harm from a serious chemical hazard. However, the score does not exceed 3 because no illnesses or injuries have been reported and the contamination is based on findings in other batches manufactured at the facility, making this a theoretical exposure risk.
Plain-English summary
The FDA is recalling Secret Dry Spray Antiperspirant in Waterlily scent, 3.8 oz spray cans, manufactured by Procter & Gamble, due to potential benzene contamination at the production facility.
The recall was initiated due to a manufacturing quality control deviation (CGMP deviation). Other batches of the product manufactured at this same facility tested positive for benzene, a hazardous chemical. All product lots with expiration dates through September 2023 are included in this recall.
The recalled product was distributed nationwide across the United States and Puerto Rico, as well as in multiple international locations including Canada, Fiji, the Bahamas, Costa Rica, Panama, and others.
Consumers should discontinue use of the product immediately. Those who have the recalled product should stop using it and may contact Procter & Gamble or the FDA for further information.
The recalled product
- Product
- Secret, Dry Spray, Aluminum chlorohydrate 23.5% Antiperspirant, Waterlily, Topical Spray Can, Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-381-10; UPC 0 37000 72372 1; 12/pack UPC 0 37000 72991 4
- Manufacturer
- The Procter & Gamble Company
- Category
- Drug — Topical Antiperspirant
- Hazard
- benzene
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots with expiry through September 2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01